Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Zobacz

español (ES) (288.28 KB - PDF)

Zobacz

čeština (CS) (322.23 KB - PDF)

Zobacz

dansk (DA) (287.53 KB - PDF)

Zobacz

Deutsch (DE) (289.53 KB - PDF)

Zobacz

eesti (ET) (276.29 KB - PDF)

Zobacz

ελληνικά (EL) (335.21 KB - PDF)

Zobacz

français (FR) (289.25 KB - PDF)

Zobacz

hrvatski (HR) (307.68 KB - PDF)

Zobacz

latviešu (LV) (334.28 KB - PDF)

Zobacz

Malti (MT) (324.47 KB - PDF)

Zobacz

Nederlands (NL) (287.82 KB - PDF)

Zobacz

polski (PL) (380.69 KB - PDF)

Zobacz

português (PT) (288.12 KB - PDF)

Zobacz

română (RO) (482.45 KB - PDF)

Zobacz

slovenčina (SK) (324.97 KB - PDF)

Zobacz

slovenščina (SL) (318.42 KB - PDF)

Zobacz

suomi (FI) (285.73 KB - PDF)

Zobacz

svenska (SV) (287.15 KB - PDF)

Zobacz

Product information

български (BG) (936.84 KB - PDF)

Zobacz

español (ES) (457.64 KB - PDF)

Zobacz

čeština (CS) (695.23 KB - PDF)

Zobacz

dansk (DA) (443.55 KB - PDF)

Zobacz

Deutsch (DE) (456.17 KB - PDF)

Zobacz

eesti (ET) (460.88 KB - PDF)

Zobacz

ελληνικά (EL) (957.24 KB - PDF)

Zobacz

français (FR) (383.63 KB - PDF)

Zobacz

hrvatski (HR) (504.46 KB - PDF)

Zobacz

italiano (IT) (614.01 KB - PDF)

Zobacz

latviešu (LV) (750.12 KB - PDF)

Zobacz

lietuvių (LT) (673.01 KB - PDF)

Zobacz

magyar (HU) (1.07 MB - PDF)

Zobacz

Malti (MT) (774.79 KB - PDF)

Zobacz

Nederlands (NL) (445.92 KB - PDF)

Zobacz

polski (PL) (1.09 MB - PDF)

Zobacz

português (PT) (456.69 KB - PDF)

Zobacz

română (RO) (807.04 KB - PDF)

Zobacz

slovenčina (SK) (711.68 KB - PDF)

Zobacz

slovenščina (SL) (702.28 KB - PDF)

Zobacz

suomi (FI) (456.54 KB - PDF)

Zobacz

svenska (SV) (441.7 KB - PDF)

Zobacz

Íslenska (IS) (622.5 KB - PDF)

Zobacz

norsk (NO) (656.3 KB - PDF)

Zobacz
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Zobacz

español (ES) (219.22 KB - PDF)

Zobacz

čeština (CS) (262.67 KB - PDF)

Zobacz

dansk (DA) (227.42 KB - PDF)

Zobacz

Deutsch (DE) (218.75 KB - PDF)

Zobacz

eesti (ET) (221.16 KB - PDF)

Zobacz

ελληνικά (EL) (268.37 KB - PDF)

Zobacz

français (FR) (221.14 KB - PDF)

Zobacz

hrvatski (HR) (227.55 KB - PDF)

Zobacz

italiano (IT) (191.92 KB - PDF)

Zobacz

latviešu (LV) (256.74 KB - PDF)

Zobacz

lietuvių (LT) (210.34 KB - PDF)

Zobacz

magyar (HU) (210.45 KB - PDF)

Zobacz

Malti (MT) (250.85 KB - PDF)

Zobacz

Nederlands (NL) (228.06 KB - PDF)

Zobacz

polski (PL) (245.92 KB - PDF)

Zobacz

português (PT) (231.37 KB - PDF)

Zobacz

română (RO) (434.62 KB - PDF)

Zobacz

slovenčina (SK) (253.67 KB - PDF)

Zobacz

slovenščina (SL) (237.31 KB - PDF)

Zobacz

suomi (FI) (204.11 KB - PDF)

Zobacz

svenska (SV) (218.51 KB - PDF)

Zobacz

Íslenska (IS) (185.95 KB - PDF)

Zobacz

norsk (NO) (222.67 KB - PDF)

Zobacz

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page